US Earnings Financial Results SEC Filings — April 02, 2026

02-04-2026

Algorhythm Holdings, Inc. (RIME) filed its 10-K on April 02, 2026, highlighting a history of losses and substantial doubt about its ability to continue as a going concern, as stated in the audit report by M&K CPAs, PLLC for the year ended December 31, 2025. The filing details extensive risks including the need for additional capital, material weaknesses in internal controls over financial reporting, dependence on market acceptance of its SemiCab technology platform, cyber threats, geopolitical tensions, and potential Nasdaq delisting. No positive financial performance metrics were provided, with ongoing challenges from prior Singing Machine business sale and operational strains.

• ·Company identified material weaknesses in internal control over financial reporting during assessment for audited consolidated financial statements.
• ·Risks include potential Nasdaq delisting if continued listing requirements not met.
• ·Never paid dividends on common stock and does not intend to in foreseeable future.

02-04-2026

VITASPRING BIOMEDICAL CO. LTD. reported no revenues for Q1 FY2025, resulting in a net loss of $216,831, improved from $304,601 in Q1 FY2024 due to lower SG&A expenses (down 28.8% YoY). However, total assets declined 4.4% QoQ to $131,288, cash burn from operations improved to only $4,023 (vs. $27,940 YoY), but stockholders' deficit worsened to $(3,525,803) amid rising liabilities.

• ·Equipment and vehicle, net declined to $21,574 from $24,063 QoQ.
• ·Operating lease right-of-use asset decreased to $45,407 from $89,652 QoQ.
• ·Stock-based compensation expense of $41,217 in Q1 FY2025, similar to $41,216 in prior year.
• ·Accounts receivable net at $0 with full allowance of $33,632.

02-04-2026

DYNARESOURCE, INC. reported revenue of $58,467,565 in 2025, up 25.7% YoY from $46,503,016, achieving gross profit of $17,279,995 and net income of $3,817,103 versus prior-year loss of $8,521,443, with operating cash flow turning positive at $5,757,148 from -$8,014,004. However, total comprehensive loss was $3,041,711 due to a $6,858,814 foreign currency translation loss, total liabilities surged 66.4% to $52,834,056, and stockholders' equity flipped to a $1,094,950 deficiency from $909,552. Total assets grew 49.5% to $57,596,586, driven by higher mineral properties.

• ·Mine production parameters: 7-year life, 230 ktpa rate, 190 koz gold equivalent payable, AISC $1,720/oz AuEq.
• ·Basic EPS $0.12 in 2025 vs -$0.35 in 2024.
• ·Credit line balance $15M (current + non-current) at year-end 2025.
• ·2024 financials restated (Note 2).

02-04-2026

For the three months ended February 28, 2026, FactSet revenues grew 7% YoY to $611M, but operating income was slightly down 0.3% to $185M and net income declined 8% to $133M amid higher cost of services and SG&A expenses. Over six months, revenues rose 7% YoY to $1.22B with operating income flat at $377M and net income down 3% to $286M; however, operating cash flow surged 28% to $333M, funding $303M in share repurchases.

• ·Cash and cash equivalents decreased to $268M from $338M at August 31, 2025.
• ·Total assets declined to $4.22B from $4.30B at August 31, 2025.
• ·Long-term debt stable at approximately $1.37B.
• ·No acquisitions in six months ended February 28, 2026 (vs $342M in prior year).
• ·Dividends declared $81M for six months ended February 28, 2026.

02-04-2026

Lovesac Co reported FY2026 net sales of $697,115 thousand, up 2.4% YoY from $680,628 thousand in FY2025, driven by 10.0% growth in showroom sales to $468,007 thousand, however internet sales declined 2.0% to $192,349 thousand and other sales plunged 37.1% to $36,759 thousand. Operating income fell 60.7% to $5,363 thousand with gross margin contracting 210 basis points to 56.4%, leading to net income of $4,065 thousand, down 64.8% YoY, while operating cash flow improved 26.5% to $49,328 thousand and ending cash rose to $101,853 thousand. Total assets edged up to $534,682 thousand from $532,250 thousand, supported by lower inventories and share repurchases.

• ·Merchandise inventories declined to $106,317 thousand from $124,333 thousand YoY.
• ·Share repurchases in FY2026 totaled $6,046 thousand, reducing shares outstanding to 14,617,238.
• ·Property and equipment, net increased to $86,400 thousand from $77,990 thousand.
• ·Equity-based compensation expense was $5,510 thousand in FY2026.

02-04-2026

Acuity Inc. reported strong YoY growth for the six months ended February 28, 2026, with net sales up 12.3% to $2,199.4 million and net income increasing 18.0% to $217.3 million, supported by 17.1% higher gross profit and 20.5% growth in operating profit. For the three months ended February 28, 2026, net sales rose 4.9% to $1,055.7 million and net income grew 24.9% to $96.8 million. However, cash and cash equivalents declined to $272.5 million from $422.5 million at fiscal year-end August 31, 2025, reflecting $200.0 million in term loan repayments and $103.0 million in common stock repurchases, while total assets decreased to $4,558.5 million.

• ·Operating cash flow increased 20.0% YoY to $229.9 million for six months ended February 28, 2026.
• ·Long-term debt reduced to $697.1 million from $896.8 million at August 31, 2025 following $200.0 million repayments.
• ·Special charges of $5.9 million recorded in current three and six months periods.
• ·Diluted EPS for six months $6.91 vs $5.80 YoY (+19.1%).
• ·Stockholders' equity increased to $2,840.8 million from $2,724.9 million.

02-04-2026

TD SYNNEX reported robust YoY growth for the three months ended February 28, 2026, with revenue up 18.1% to $17,161,198 thousand, gross profit up 25.5% to $1,252,146 thousand, operating income up 60.8% to $489,360 thousand, and net income nearly doubling to $326,915 thousand (diluted EPS $4.04 vs $1.98). However, net cash used in operating activities increased 19.7% to $895,866 thousand YoY amid a $1,476,655 thousand QoQ rise in inventories, resulting in cash and equivalents declining 35.9% QoQ to $1,562,557 thousand. Stockholders' equity grew 4.0% QoQ to $8,782,736 thousand, supported by net income, though offset by $80,197 thousand in common stock repurchases and $38,742 thousand in dividends.

• ·Diluted EPS of $4.04 for three months ended February 28, 2026, up from $1.98 YoY.
• ·Cash dividends declared per share $0.48 vs $0.44 YoY.
• ·Repurchases of common stock $80,197 thousand during the period.
• ·SG&A expenses increased 10.0% YoY to $762,786 thousand.
• ·Foreign currency translation adjustments contributed $85,097 thousand to other comprehensive income.

02-04-2026

Lindsay Corporation reported significantly lower operating revenues of $157.7M for the three months ended February 28, 2026, down 15.7% YoY from $187.1M, driven by sharp declines in Infrastructure segment revenues (-57.7% to $16.5M) while Irrigation was down mildly (-4.6% to $141.2M); for the six months, revenues fell 11.3% YoY to $313.5M from $353.3M, with net earnings dropping 34.7% to $28.6M from $43.7M. Despite the declines, the company generated $24.0M in operating cash flow (down from $33.9M), maintained a strong cash position of $186.1M, and repurchased $55.5M in common shares, signaling confidence in its balance sheet.

• ·Operating cash flow for six months ended Feb 28, 2026 was $24.0M, down from $33.9M YoY.
• ·Total assets as of Feb 28, 2026 stood at $837.7M, up from $814.2M prior year but down slightly from $840.8M at Aug 31, 2025.
• ·Shareholders' equity decreased to $507.8M from $532.9M at Aug 31, 2025, primarily due to $55.5M share repurchases.
• ·Inventories net $144.6M as of Feb 28, 2026, down from $154.6M prior year.

02-04-2026

IRIDEX Corp reported total revenues of $52,675 thousand for the year ended January 3, 2026, up 8.2% YoY from $48,669 thousand, with Cyclo G6 up 9.0% to $13,843 thousand, Retina up 8.8% to $30,280 thousand, and Other up 5.0% to $8,552 thousand. However, gross margin declined to 36.5% from 40.1% due to cost of revenues rising to 63.5% of revenue from 59.9%, and gross profit slightly decreased to $19,227 thousand from $19,502 thousand. Net loss narrowed to $4,437 thousand (8.4% of revenue) from $8,910 thousand (18.2%), with operating expenses reduced to 41.4% of revenue from 57.1%, cash and equivalents rising to $6,028 thousand from $2,387 thousand, and stockholders' equity improving to $4,922 thousand from $2,097 thousand.

• ·Inventories decreased to $7,877 thousand from $10,817 thousand.
• ·Deferred revenue decreased to $8,961 thousand from $10,526 thousand.
• ·Net cash used in operating activities improved to $2,115 thousand from $7,285 thousand.
• ·Issuance of Series B preferred stock: 600,000 shares with $6.0 million liquidation preference.

02-04-2026

Navan, Inc. reported FY2026 revenue of $702M, up 31% YoY from $537M, with usage-based revenue growing 31% to $640M and subscription revenue up 33% to $62M; gross profit increased 36% to $500M, expanding margin to 71% from 68%. However, net loss widened significantly to $398M from $181M, driven by operating expenses rising to 99% of revenue (from 89%), with sales and marketing up 57% to $343M, plus one-time losses including $118M on debt extinguishment and $47M in fair value adjustments. Loss from operations deteriorated to $197M from $108M.

• ·Cost of revenue increased 19% YoY to $202M.
• ·Research and development expenses rose to $151M from $122M YoY.
• ·Stock-based compensation expense more than doubled to $182M from $77M YoY.
• ·Compared to FY2024, FY2026 revenue grew 75% from $402M, but net loss improved from $332M only modestly in magnitude.

02-04-2026

Iron Horse Acquisition II Corp., a SPAC, completed its IPO in the three months ended February 28, 2026, funding the Trust Account with $231,461,856 from 23,000,000 redeemable Class A ordinary shares at $10.06 per share, generating net income of $1,358,897 versus a $72,670 loss YoY, driven by $1,636,856 in interest income. However, general, formation, and operational costs rose 282% YoY to $277,959, resulting in an operating loss increase, while shareholders’ deficit ballooned to $(10,166,725) from $(173,666) due to $20,209,972 accretion on redeemable shares. Cash balance grew to $718,100 from $432 QoQ amid IPO proceeds.

• ·Ordinary shares redemption value of $10.06 per share.
• ·Promissory note – related party fully repaid ($300,000).
• ·Net cash used in operating activities: $473,126 (2026) vs. $51,470 (2025).
• ·Deferred offering costs cleared to $0 from $339,249 QoQ.

02-04-2026

Regional Health Properties, Inc. reported total revenues of $53.2M for the year ended December 31, 2025, a 189.9% YoY increase from $18.3M, driven by patient care revenues rising 219.8% to $36.1M and new pharmacy revenues of $11.7M. However, rental revenues declined 22.9% to $5.4M, adjusted EBITDA fell 10.3% to $3.1M from $3.5M, and net cash from operating activities turned negative at $(2.3M) versus $1.9M prior year. Net income swung to a profit of $3.4M from a $3.2M loss, boosted by one-time gains including a $5.8M bargain purchase and $2.7M asset sale.

• ·Total assets increased to $67.8M from $60.5M; total liabilities decreased slightly to $62.8M from $63.4M.
• ·Gain on bargain purchase of $5.8M and gain on asset sale of $2.7M in 2025.
• ·Cash and restricted cash ending balance $6.1M vs $3.5M.
• ·EPS basic $1.09 in 2025 vs ($1.73) in 2024.
• ·Acquisition of SunLink resulted in issuance of 1,405 Series D preferred shares.

02-04-2026

Trilogy Metals Inc. reported a loss and comprehensive loss of $7,063 thousand for the three months ended February 28, 2026, more than doubling from $3,623 thousand YoY due to higher general and administrative expenses, salaries, stock-based compensation, share of loss from Ambler Metals LLC, and loss on derivative. Cash and cash equivalents declined 7.4% QoQ to $47,784 thousand, with operating cash usage increasing to $2,741 thousand and a $2,500 thousand investment in Ambler Metals LLC. However, the investment in Ambler Metals LLC rose 1.1% QoQ to $106,420 thousand, and cash remains up 89.5% YoY while shareholders' equity stood at $121,484 thousand.

• ·Derivative liability increased to 32,257 thousand as of February 28, 2026 from 30,743 thousand QoQ
• ·Stock-based compensation expense of 3,096 thousand, up from 2,230 thousand YoY
• ·Ambler Metals LLC total assets increased to 38,904 thousand from 35,709 thousand QoQ
• ·Proceeds from issuance of common shares: 1,164 thousand during the period

02-04-2026

ChargePoint Holdings, Inc. reported FY2026 revenue of $411,224 thousand, with Networked Charging Systems declining 7.8% YoY to $216,514 thousand (52.7% of total) while Subscriptions grew 12.5% YoY to $162,387 thousand (39.5% of total). Gross profit rose 24.8% to $125,602 thousand with margin expanding to 30.5% from 24.1%, but Other revenue fell 14.8% to $32,323 thousand and R&D expenses were flat at $139,272 thousand (33.9% of revenue).

• ·Networked Charging Systems was 52.7% of total revenue in FY2026 (down from 56.3% in FY2025)
• ·Subscriptions was 39.5% of total revenue in FY2026 (up from 34.6% in FY2025)
• ·Cost of Networked Charging Systems revenue declined 10.6% YoY to $199,668 thousand
• ·Cost of Subscriptions revenue declined 13.1% YoY to $61,875 thousand

02-04-2026

Caleres Inc reported FY2025 consolidated net sales of $2,757.9 million, up 1.3% from $2,722.7 million in FY2024, driven by 7.3% growth in Brand Portfolio segment to $1,316.0 million; however, Famous Footwear segment sales declined 3.6% to $1,500.1 million with comparable sales down 2.3%, gross margin compressed to 43.0% from 44.9%, and operating earnings plummeted 95.8% to $6.4 million, resulting in a net loss attributable to Caleres of $6.7 million versus $107.3 million profit prior year. The acquisition of Stuart Weitzman for $108.9 million on August 4, 2025, added $102.2 million in sales but incurred $27.6 million in costs. Diluted EPS swung to ($0.21) from $3.09.

• ·Restructuring and other special charges increased to $20.9 million (0.8% of net sales) in FY2025 from $7.1 million (0.3%) in FY2024.
• ·Selling and administrative expenses rose to $1,157.5 million (42.0% of net sales) from $1,065.0 million (39.1%) YoY.
• ·FY2025 net loss before taxes: ($12.2) million vs $135.2 million earnings in FY2024.

02-04-2026

SCORES HOLDING CO INC reported Q2 FY2024 revenue of $73,500, down 43% YoY from $129,500, while six-month revenue fell 28% YoY to $147,000 from $203,000; however, net income improved significantly to $54,769 for the six months (up 95% YoY) driven by sharply lower G&A expenses ($92,231 vs $174,300). Cash and cash equivalents plummeted to $334 as of June 30, 2024 from $46,624 at year-end 2023, with net cash used in operations at ($46,290) versus provided by $44,568 YoY. Stockholders' deficit narrowed to ($564,906) from ($619,675), reflecting profitability gains amid revenue declines.

• ·G&A expenses for six months ended June 30, 2024: $92,231, down from $174,300 YoY.
• ·Contract liabilities decreased to $409,500 as of June 30, 2024 from $418,500 at Dec 31, 2023.
• ·Trade receivables net: $58,000 as of June 30, 2024 vs $63,000 at Dec 31, 2023.

02-04-2026

Starry Sea Acquisition Corp, a SPAC, reported total assets of $58,742,879 as of December 31, 2025, up significantly from $25,000 at year-end 2024, driven by $58,363,263 in the Trust Account following its IPO with 5,750,000 ordinary shares subject to redemption at $10.12 per share totaling $52,978,742. For FY 2025, the company posted net income of $320,643, boosted by $863,257 in interest income that offset a $542,614 operating loss; this compares to a $6,974 net loss in the short stub period from incorporation (December 5, 2024) to December 31, 2024. While interest income drove profitability, ongoing formation and operating costs highlight pre-acquisition burn with no revenue generation yet.

• ·Date of incorporation: December 5, 2024
• ·Report of Independent Registered Public Accounting Firm (PCAOB ID: 3487)
• ·Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption: 2,252,740 for FY 2025
• ·Basic and diluted weighted average shares outstanding, ordinary shares attributable to Starry Sea: 1,613,163 for FY 2025 and 1,250,000 for 2024 stub period
• ·Promissory note - related party: $0 as of December 31, 2025 (down from $6,974)
• ·Deferred offering costs: $0 as of December 31, 2025 (down from $25,000)
• ·Subscription receivable: $0 as of December 31, 2025 (was -$25,000)

02-04-2026

AngioDynamics reported Q3 FY2026 net sales of $78,423 thousand, up 8.9% YoY to $72,004 thousand, driven by strong 19% growth in Med Tech to $37,282 thousand while Med Device grew only 1.2% to $41,141 thousand. However, operating loss widened 30% to $12,951 thousand from $9,974 thousand due to higher acquisition/restructuring costs and expenses, resulting in net loss of $8,084 thousand versus $4,407 thousand YoY. For nine months, net sales increased 10% to $233,567 thousand with operating cash use improving to $14,363 thousand from $28,939 thousand, narrowing net loss to $25,337 thousand from $27,943 thousand.

• ·Total assets decreased to $260,678 thousand at Feb 28, 2026 from $280,144 thousand at May 31, 2025.
• ·Net cash used in operating activities improved to $14,363 thousand for 9M FY2026 from $28,939 thousand.
• ·Foreign currency translation gain of $1,708 thousand in Q3 contributed to other comprehensive income.

02-04-2026

Byrn, Inc., a shell company with zero public float, reported no revenue for the year ended December 31, 2025, continuing from 2024, with net loss improving slightly to $40,025 from $44,987 (11% reduction). Operating expenses declined to $40,025 from $44,987, consisting entirely of related-party administrative costs. However, total liabilities rose 71% to $96,612 from $56,586, primarily due to increased related-party payables, while total assets remained at zero and cash flows showed ongoing reliance on related-party financing to offset operating cash burn.

• ·Entity designated as shell company: true
• ·Entity Public Float: $0
• ·Entity Small Business: true
• ·Entity Emerging Growth Company: true
• ·Cash at beginning and end of periods: $0 for both years
• ·Net cash provided by financing (related party loans) exactly offset operating cash use in both years